Date Filed | Type | Description |
08/09/2023 |
4
| ORTENZIO ROBERT A (EXECUTIVE CHAIRMAN) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Sold 50,000 shares
@ $29.52, valued at
$1.5M
|
|
08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/03/2023 |
8-K
| Quarterly results |
08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/02/2023 |
4
| CRESSEY BRYAN C (Director) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 216 shares
@ $29.92, valued at
$6.5k
|
|
08/02/2023 |
4
| TAVENNER MARILYN B (Director) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 10,000 shares
@ $0 |
|
08/02/2023 |
4
| Thomas Daniel (Director) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 10,000 shares
@ $0 |
|
08/02/2023 |
4
| Khanuja Parvinderjit S. (Director) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 602 shares
@ $29.92, valued at
$18k
Granted 10,000 shares
@ $0 |
|
08/02/2023 |
4
| Frist William H. (Director) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 602 shares
@ $29.92, valued at
$18k
Granted 10,000 shares
@ $0 |
|
08/02/2023 |
4
| Ely James S. III (Director) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 602 shares
@ $29.92, valued at
$18k
Granted 10,000 shares
@ $0 |
|
08/02/2023 |
4
| Davisson Katherine R (Director) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 10,000 shares
@ $0 |
|
08/02/2023 |
4
| Mullin Thomas P (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 75,000 shares
@ $0 |
|
08/02/2023 |
4
| Saich John A. (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 75,000 shares
@ $0 |
|
08/02/2023 |
4
| ORTENZIO ROCCO A (EXECUTIVE CHAIRMAN) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 150,000 shares
@ $0 |
|
08/02/2023 |
4
| ORTENZIO ROBERT A (EXECUTIVE CHAIRMAN) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Granted 250,000 shares
@ $0 |
|
08/02/2023 |
4
| CHERNOW DAVID S (PRESIDENT AND CEO) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Paid exercise price by delivering 36,825 shares
@ $29.92, valued at
$1.1M
Granted 250,000 shares
@ $0 |
|
08/02/2023 |
4
| JACKSON MARTIN F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Paid exercise price by delivering 22,095 shares
@ $29.92, valued at
$661.1k
Granted 150,000 shares
@ $0 |
|
08/02/2023 |
4
| TARVIN MICHAEL E (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Paid exercise price by delivering 14,730 shares
@ $29.92, valued at
$440.7k
Granted 100,000 shares
@ $0 |
|
08/02/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/01/2023 |
8-K
| Quarterly results |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2023 |
8-K
| Quarterly results |
07/11/2023 |
4
| ORTENZIO ROBERT A (EXECUTIVE CHAIRMAN) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Sold 50,000 shares
@ $30.36, valued at
$1.5M
|
|
07/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/30/2023 |
4
| ORTENZIO ROBERT A (EXECUTIVE CHAIRMAN) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Sold 100,000 shares
@ $32, valued at
$3.2M
|
|
06/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/09/2023 |
4
| ORTENZIO ROBERT A (EXECUTIVE CHAIRMAN) has filed a Form 4 on SELECT MEDICAL HOLDINGS CORP
Txns:
| Sold 50,000 shares
@ $28.63, valued at
$1.4M
|
|
06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data
Docs:
|
"Amendment No. 7, to the Credit Agreement, by and among Select Medical Holdings Corporation, Select Medical Corporation, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other lenders and issuing banks party thereto, as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, and Amendment No. 6" |
|
|